Endometrial Cancer is cancer that arises in the lining of the uterus (or endometrium). Over 90% of all uterine cancer cases are endometrial cancer, so the terms “uterine cancer” and “endometrial cancer” are often used interchangeably.
Uterine Sarcoma, a much rarer form of uterine cancer, is cancer that forms in the muscles of the uterus or other tissues that support the uterus. Uterine sarcoma is more aggressive and harder to treat than endometrial cancer.
Uterine cancer is the most common type of gynecologic cancer and the 4th most common cancer for women in the United States.
The lifetime risk for uterine cancer is 1 in 37.
An estimated 65,620 women in the United States will be diagnosed with uterine cancer in 2020.
An estimated 12,590 women in the United States are expected to die of uterine cancer in 2020.
Approximately 793,846 women are currently living with a uterine cancer diagnosis.
When caught early, uterine cancer can be effectively treated and is less likely to return.
Overall, 81.2% of women live 5 or more years after a uterine cancer diagnosis.
Despite similar diagnosis rates, 5-year survival is lower in black versus white women (62% vs 83%).
Uterine cancer is one of the few cancers with increasing annual diagnoses and deaths.